C2FB581B-31F5-4FA9-87A2-0989E3B3A800.jpeg

Infanrix Hexa (DTaP/IPV/Hib/HepB), made by Glaxosmithkline, is a 6- in- 1 vaccine which was released onto the global market in the year 2000, and since then across 97 countries around the world including Europe, Canada, Australia and New Zealand. It aims to protect against Diphtheria, Tetanus, Pertussis, Polio, Hib & Hepatitis B.

It was added to the UK vaccination schedule on 1st August 2017, with the sole purpose of introducing Hepatitis B into routine infant vaccinations. It is scheduled to be given at 8, 12 & 16 weeks of age and is to be administered alongside other recommended vaccines from the NHS Immunisation Schedule at age appropriate appointments.(ref 1)

[READ MORE]

You may also like

There is something wrong with Feed URL